Cullinan Therapeutics Inc (CGEM) USD0.0001
0.26%- This stock can be held in a
Create an alert
Stocks and Shares ISASell:$8.34
Buy:$8.35
Change:
$0.47
(6.03%)
$0.47
(6.03%)Market closed |
Prices delayed by at least 15 minutes
Sell:$8.34
Buy:$8.35
Change:$0.47
(6.03%)
$0.47
(6.03%)Market closed |
Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 28 October 2025 | LYNX1 CAPITAL MANAGEMENT LPHedge Fund | Buy Regular purchase transaction | 165,667 | $8.40 | $1,391,685.63 | 8,963,500 |
| 17 October 2025 | LYNX1 CAPITAL MANAGEMENT LPHedge Fund | Buy Regular purchase transaction | 32,217 | $7.84 | $252,565.17 | 8,797,833 |
| 16 October 2025 | LYNX1 CAPITAL MANAGEMENT LPHedge Fund | Buy Regular purchase transaction | 150,000 | $8.86 | $1,328,250.00 | 8,765,616 |
| 15 October 2025 | LYNX1 CAPITAL MANAGEMENT LPHedge Fund | Buy Regular purchase transaction | 51,500 | $7.94 | $409,049.05 | 8,615,616 |
| 14 October 2025 | LYNX1 CAPITAL MANAGEMENT LPHedge Fund | Buy Regular purchase transaction | 15,032 | $7.59 | $114,047.78 | 8,564,116 |
| 10 October 2025 | LYNX1 CAPITAL MANAGEMENT LPHedge Fund | Buy Regular purchase transaction | 277,298 | $7.36 | $2,041,384.69 | 8,549,084 |
| 9 October 2025 | LYNX1 CAPITAL MANAGEMENT LPHedge Fund | Buy Regular purchase transaction | 626,043 | $6.70 | $4,191,858.72 | 8,271,786 |
| 8 October 2025 | LYNX1 CAPITAL MANAGEMENT LPHedge Fund | Buy Regular purchase transaction | 556,300 | $6.46 | $3,593,698.00 | 7,645,743 |
| 25 February 2025 | Nadim AhmedPresident/CEO | Sell Tax related | 12,529 | $8.53 | $106,872.37 | 430,621 |
| 25 February 2025 | Jeffrey Alan JonesChief Level Officer | Sell Tax related | 4,895 | $8.53 | $41,754.35 | 174,164 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 9 October 2025 | LYNX1 CAPITAL MANAGEMENT LPHedge Fund | Buy Regular purchase transaction | 626,043 | $6.70 | $4,191,858.72 | 8,271,786 |
| 8 October 2025 | LYNX1 CAPITAL MANAGEMENT LPHedge Fund | Buy Regular purchase transaction | 556,300 | $6.46 | $3,593,698.00 | 7,645,743 |
| 10 October 2025 | LYNX1 CAPITAL MANAGEMENT LPHedge Fund | Buy Regular purchase transaction | 277,298 | $7.36 | $2,041,384.69 | 8,549,084 |
| 28 October 2025 | LYNX1 CAPITAL MANAGEMENT LPHedge Fund | Buy Regular purchase transaction | 165,667 | $8.40 | $1,391,685.63 | 8,963,500 |
| 16 October 2025 | LYNX1 CAPITAL MANAGEMENT LPHedge Fund | Buy Regular purchase transaction | 150,000 | $8.86 | $1,328,250.00 | 8,765,616 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.